{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:03:42Z","timestamp":1787238222000,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1053\/j.ajkd.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T07:38:40Z","timestamp":1568014720000},"page":"138-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report"],"prefix":"10.1053","volume":"75","author":[{"given":"Christie","family":"Rampersad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Nickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.ajkd.2019.06.010_bib1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.14746","article-title":"Carpe diem-time to transition from empiric to precision medicine in kidney transplantation","volume":"18","author":"Wiebe","year":"2018","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2019.06.010_bib2","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2019.06.010_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2019.06.010_bib4","first-page":"434","article-title":"Impact of non-human leukocyte antigen-specific antibodies in kidney and heart transplantation","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.06.010_bib5","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1172\/JCI117214","article-title":"Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells","volume":"93","author":"Witzgall","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2019.06.010_bib6","doi-asserted-by":"crossref","first-page":"R861","DOI":"10.1152\/ajpregu.00384.2005","article-title":"Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins","volume":"290","author":"Villanueva","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.06.010_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1681\/ASN.2014070679","article-title":"Markers of endothelial-to-mesenchymal transition: evidence for antibody-endothelium interaction during antibody-mediated rejection in kidney recipients","volume":"27","author":"Xu-Dubois","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2019.06.010_bib8","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/ajt.15340","article-title":"Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss","volume":"19","author":"Louis","year":"2019","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2019.06.010_bib9","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1097\/TXD.0000000000000925","article-title":"Hyperacute antibody-mediated rejection associated with red blood cell antibodies","volume":"5","author":"Shaw","year":"2019","journal-title":"Transplant Direct"},{"issue":"11","key":"10.1053\/j.ajkd.2019.06.010_bib10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.humimm.2013.06.006","article-title":"Role of anti-vimentin antibodies in allograft rejection","volume":"74","author":"Rose","year":"2013","journal-title":"Hum Immunol"},{"issue":"11","key":"10.1053\/j.ajkd.2019.06.010_bib11","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.humimm.2013.06.014","article-title":"Vimentin antibody production in transplant patients and immunomodulatory effects of vimentin in-vitro","volume":"74","author":"Carter","year":"2013","journal-title":"Hum Immunol"},{"issue":"44","key":"10.1053\/j.ajkd.2019.06.010_bib12","doi-asserted-by":"crossref","first-page":"41237","DOI":"10.1074\/jbc.M105648200","article-title":"Identification of a caspase-9 substrate and detection of its cleavage in programmed cell death during mouse development","volume":"276","author":"Nakanishi","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1053\/j.ajkd.2019.06.010_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1189\/jlb.0405190","article-title":"Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis","volume":"79","author":"Moisan","year":"2006","journal-title":"J\u00a0Leuk Biol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.06.010_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1546-0096-11-31","article-title":"Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis","volume":"11","author":"Gilliam","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"10.1053\/j.ajkd.2019.06.010_bib15","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s10067-016-3355-1","article-title":"Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA)","volume":"35","author":"Lipinska","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1053\/j.ajkd.2019.06.010_bib16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.ajkd.2019.06.010_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ctr.12567","article-title":"Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population","volume":"29","author":"Young","year":"2015","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2019.06.010_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.tp.0000166920.18998.15","article-title":"The autoimmune response to vimentin after renal transplantation in nonhuman primates is immunosuppression dependent","volume":"80","author":"Jonker","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.ajkd.2019.06.010_bib19","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.transproceed.2016.04.009","article-title":"Anti-vimentin antibodies present at the time of transplantation may predict early development of interstitial fibrosis\/tubular atrophy","volume":"48","author":"Lopez-Soler","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1053\/j.ajkd.2019.06.010_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.trim.2017.09.001","article-title":"Immunoglobulin isotype switching of antibodies to vimentin is associated with development of transplant glomerulopathy following human renal transplantation","volume":"45","author":"Gunasekaran","year":"2017","journal-title":"Transpl Immunol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.06.010_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.TP.0000443224.66960.37","article-title":"Role of anti-vimentin antibodies in renal transplantation","volume":"98","author":"Besarani","year":"2014","journal-title":"Transplantation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619308856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619308856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:25:16Z","timestamp":1759461916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619308856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0272638619308856"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.06.010","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}